9 months ago
RVMD
AnalystsPeter LawsonPeter Lawson's Stock Forecasts
AnalystsPeter Lawson
Analyst Ranking
Bottom 5%
#4660 out of 4870 analysts
Average Return
-8.9%
Win Rate
34%31 out of 91
Risk vs Reward
Poor
Good
Peter Lawson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunogen IncIMGN | +214.57% | $5.01 | $15.76 | 2022-11-15 - 2023-11-14 | Strong Buy |
Immunogen IncIMGN | +187.55% | $5.46 | $15.70 | 2022-09-09 - 2023-09-08 | Strong Buy |
Immunomedics IncIMMU | +171.17% | $32.40 | $87.86 | 2020-05-05 - 2020-10-22 | Strong Buy |
Fate Therapeutics IncFATE | +170.37% | $30.75 | $83.14 | 2020-03-04 - 2021-03-04 | Strong Buy |
Syndax Pharmaceuticals IncSNDX | +100.18% | $11.28 | $22.58 | 2020-03-04 - 2021-03-04 | Strong Buy |
Peter Lawson Analyst Color
Get additional color on Peter Lawson's coverage of popular stocks
a year ago
MGNX
a year ago
ARVN
a year ago
MGNX
a year ago
SWTX
a year ago
EXEL
a year ago
SWTX
2 years ago
SNDX
2 years ago
IMGN
Peter Lawson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bicycle Therapeutics PLCBCYC | 2 | Strong Buy | $15.00 | +65.20% | Maintains | a day ago |
Springworks Therapeutics IncSWTX | 4 | Hold | $47.00 | +1.71% | Downgrades | 5 days ago |
Arcus Biosciences IncRCUS | 7 | Strong Buy | $14.00 | +62.41% | Maintains | 10 days ago |
Iovance Biotherapeutics IncIOVA | 5 | Strong Buy | $5.00 | +50.15% | Maintains | 18 days ago |
Biomea Fusion IncBMEA | 5 | Hold | $3.00 | +47.78% | Maintains | a month ago |
Tscan Therapeutics IncTCRX | 2 | Strong Buy | $3.00 | +93.55% | Maintains | 2 months ago |
Geron CorpGERN | 1 | Strong Buy | $4.00 | +179.72% | Maintains | 2 months ago |
Exelixis IncEXEL | 5 | Hold | $29.00 | -25.43% | Maintains | 3 months ago |
Arvinas IncARVN | 7 | Strong Buy | $32.00 | +342.60% | Maintains | 3 months ago |
Revolution Medicines IncRVMD | 3 | Strong Buy | $60.00 | +47.64% | Maintains | 7 months ago |
Relay Therapeutics IncRLAY | 5 | Strong Buy | $17.00 | +416.72% | Maintains | 8 months ago |
Syndax Pharmaceuticals IncSNDX | 3 | Strong Buy | $33.00 | +138.78% | Maintains | 9 months ago |
Exscientia PLCEXAI | 4 | Hold | $5.00 | +3.31% | Downgrades | 9 months ago |
Immunocore Holdings PLCIMCR | 2 | Strong Buy | $66.00 | +118.91% | Maintains | 9 months ago |
Macrogenics IncMGNX | 8 | Strong Buy | $8.00 | +376.19% | Maintains | 9 months ago |
Blueprint Medicines CorpBPMC | 9 | Hold | $105.00 | +5.79% | Maintains | 9 months ago |
Nurix Therapeutics IncNRIX | 2 | Strong Buy | $31.00 | +177.78% | Maintains | 10 months ago |
Replimune Group IncREPL | 3 | Strong Buy | $17.00 | +76.35% | Maintains | a year ago |
Tango Therapeutics IncTNGX | 1 | Strong Buy | $13.00 | +821.99% | Maintains | a year ago |
Deciphera Pharmaceuticals IncDCPH | 6 | Hold | $26.00 | N/A | Upgrades | a year ago |
Fate Therapeutics IncFATE | 3 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Immunogen IncIMGN | 5 | Hold | $31.00 | N/A | Downgrades | a year ago |
Adaptimmune Therapeutics PLCADAP | 2 | Strong Sell | $1.00 | N/A | Maintains | 2 years ago |
Prelude Therapeutics IncPRLD | 4 | Hold | $5.00 | N/A | Maintains | 2 years ago |
Neximmune IncNEXI | 2 | Strong Buy | $50.00 | N/A | Maintains | 3 years ago |
Karyopharm Therapeutics IncKPTI | 2 | Strong Buy | $120.00 | N/A | Maintains | 3 years ago |
Cytomx Therapeutics IncCTMX | 3 | Strong Buy | $3.50 | N/A | Maintains | 3 years ago |
Illumina IncILMN | 1 | Strong Sell | $365.00 | N/A | Maintains | 4 years ago |
Agios Pharmaceuticals IncAGIO | 2 | Strong Buy | $46.00 | N/A | Upgrades | 5 years ago |
Immunomedics IncIMMU | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Epizyme IncEPZM | 1 | Strong Buy | $33.00 | N/A | Initiates Coverage On | 5 years ago |
Xencor IncXNCR | 1 | Strong Sell | $28.00 | N/A | Initiates Coverage On | 5 years ago |
Nektar TherapeuticsNKTR | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 5 years ago |
Tesaro IncTSRO | 1 | Hold | $75.00 | N/A | Downgrades | 6 years ago |
Celyad Oncology SaCYADY | 1 | Strong Buy | $49.00 | N/A | Initiates Coverage On | 7 years ago |
Editas Medicine IncEDIT | 1 | Strong Buy | $45.00 | N/A | Upgrades | 7 years ago |
Crispr Therapeutics AgCRSP | 1 | Strong Buy | $45.00 | N/A | Upgrades | 7 years ago |
Juno Therapeutics IncJUNO | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Affimed NvAFMD | 1 | Strong Buy | $70.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.